8 results
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Insulin Analogs ... , Duration #Diabetes ... Peaks #Comparison #Pharmacology ... #Endocrinology ... #Timing #Timeline
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
principles of insulin ... and Duration #Diabetes ... Peaks #Comparison #Pharmacology ... #Endocrinology ... #Timing #Timeline
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
: Weight-Based Dosing ... including most 2 diabetics ... estimation #Weight #Based ... #pharmacology # ... endocrinology #diabetes
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... Summary Mechanisms ... cells, triggering insulin ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... appropriately • Weight-based ... in Type 1 Diabetes ... #Medications #pharmacology ... comparison #table #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... • Increases insulin-mediated ... #Summary #DM2 # ... diabetes #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... glucose-dependent insulin ... #Summary #DM2 # ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
-> Stimulates Insulin ... One unique thing ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology